Acquisition Announced Sponsor buyer

Timothy R. Damadian acquisition of FONAR

Announced 29 Dec 2025 · NASDAQ: FONR · US$19.00 cash per share

Advisers

FONAR

Target

Legal adviser
Meister Seelig & Fein PLLC
Valuation
Fairness opinion

FONAR

Acquirer

Legal adviser
Moritt Hock & Hamroff LLP
Target
FONAR
Acquirer
FONAR
Sponsor
Timothy R. Damadian
Target based in
United States
Buyer based in
United States (unverified)
Sector
Medtech
Tags
Medtech, Healthcare Services, Diagnostics

In the league tables

Similar deals

All medtech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.